Abstract
To clarify the clinical significance of the presence of fragmented red cells (FRC) after allogeneic bone marrow transplantation (BMT), we measured the incidence and degree of FRC and their relationships to clinical features. The percentages of FRC (%FRC) were measured in 50 patients on weeks-2,0,2,4,6,8,10, and 12. The %FRC in pre-BMT patients (mean, 0.52%; range, 0.04%–1.56%) was higher than in healthy control subjects (mean, 0.08%; range, 0.02%–0.27%). The highest %FRC (≥1.3%) were seen in 2 pre-BMT and 17 post-BMT patients. Right patients who developed thrombotic microangiopathy (TMA) showed %FRC values that were significantly higher than those in patients without TMA. However, the timing of elevated %FRC was delayed until several days after the onset of intravascular hemolysis and/or a drop in platelet count. Of the patients who did not experience TMA, 5 patients with infection and 4 patients with acute graft-versus-host disease (GVHD) also showed significant elevation of %FRC during the clinical course. Furthermore, multivariate analysis results demonstrated that TMA and infection had a statistically significant effect on the high value of %FRC. These findings indicate that the appearance of FRC is a common phenomenon in patients undergoing BMT and is not a predictive factor for the early diagnosis of TMA, although FRC is one of the main laboratory findings in TMA. Furthermore, an increased %FRC is seen in other post-BMT clinical settings, such as infection and acute GVHD.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
]References
Holler E, Kolb Hi, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation.Blood. 1989;73:2018–2024.
Rabinowe SN, Soiffer RJ, Tarbell NJ, et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies.Blood. 1991;77:1837–1844.
Pettitt AR, Clark RE. Throrabotic microangiopathy following bone marrow transplantation.Bone Marrow Transplant. 1994;14:495–504.
Zeigler ZR, Rosenfeld CS, Andrews DR III, et al. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).Am J Hematol. 1996;53:213–220.
Testa S, Manna A, Porcellini A, et al. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.Bone Marrow Transplant. 1996;18:383–388.
Kanamori H, Maruta A, Sasaki S, et al. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy.Bone Marrow Transplant. 1998;21:705–709.
Zomas A, Saso R, Powels R, et al. Red cell fragmentation (schistocytosis) after bone marrow transplantation.Bone Marrow Transplant. 1998;22:777–780.
Ravandi-Kashani F, Cortes J, Talpaz M, Kantarjian HM. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effects?Cancer. 1999;85:2583–2588.
Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplantassociated thrombotic microangiopathy: a case series.Bone Marrow Transplant. 1995;15:247–253.
Chappell ME, Keeling DM, Prentice HG, Sweny P. Hemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?Bone Marrow Transplant. 1988;3:339–347.
Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy.Transplantation. 1998;65:1645–1648.
Katayama M, Handa M, Araki Y, et al. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.Br J Haematol. 1993;84:702–710.
Natazuka T, Kajimoto K, Ogawa R, et al. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematologjcal malignancies.Bone Marrow Transplant. 1998;21:815–819.
Fuge R, Bird JM, Fraser A, et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.Br J Haematol. 2001;113:58–64.
Kalhs P, Brugger S, Schwarzinger I, et al. Microangiopathy following allogeneic bone marrow transplantation.Transplantation. 1995;60:949–957.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kanamori, H., Takaishi, Y., Takabayashi, M. et al. Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation. Int J Hematol 77, 180–184 (2003). https://doi.org/10.1007/BF02983218
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02983218